Marlyne Squatrito

No ORCID on file · 8 papers in corpus · active 2022-2026

Study types

  • article 4
  • other 2
  • dissertation 1
  • review 1

Condition tags

  • adenomyosis 6
  • endometriosis 2
  • infertility 1
other 2026
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1750026

BACKGROUND: Adenomyosis is a heterogeneous uterine disorder characterized by the presence of endometrial tissue within the myometrium. Autophagy, a key homeostatic process involved in tissue remodeling and stress adaptation, has been incons…

dissertation 2026

L’adénomyose est une pathologie utérine fréquente, associée à des douleurs pelviennes, des ménorragies et une altération de la fertilité, alors qu’aucune thérapie médicale ciblée n’est actuellement approuvée et que l’hystérectomie demeure l…

other 2026
Molecular human reproduction ·doi:10.1093/molehr/gaag009

Adenomyosis is characterized by chronic inflammation, myometrial remodeling, and subfertility, yet therapeutic options that preserve reproductive potential remain limited. Sphingosine-1-phosphate (S1P) signaling regulates immune-cell traffi…

article 2025

peer reviewed

article 2025
Molecular human reproduction ·doi:10.1093/molehr/gaaf057

Adenomyosis-the ectopic presence of endometrial glands and stroma within the myometrium-affects reproductive-age women and is associated with pain, bleeding, and subfertility, yet the immune events that precede pregnancy remain poorly defin…

review 2024
Journal of clinical medicine ·doi:10.3390/jcm13247501

Background/Objectives: Adenomyosis is a benign condition where ectopic endometrial glandular tissue is found within the uterine myometrium. Its impact on women's reproductive outcomes is substantial, primarily due to defective decidualizati…

article 2024
Reproduction (Cambridge, England) ·doi:10.1530/rep-24-0019

In brief: The impact of adenomyosis on reproductive health needs to be fully understood. By using a murine model, this study provides novel insights into the nuanced mechanisms associated with fertility challenges and offers a foundation fo…

article 2022
Journal of clinical medicine ·doi:10.3390/jcm11206164

BCL6 (B-cell lymphoma 6) is a proto-oncogene and transcriptional repressor initially described as being involved in B-cell lymphoma. Recently, this factor has been identified as a promising tissue biomarker which could be used to diagnose w…